Ganga Pharmaceuticals Q2 Results
- BSE: 539680
- NSE: -
- ISIN: INE615T01017
- Sector: Biotechnology & Drugs
BSE
13.32
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Fri 23 May, 2025 | 16:00:03
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Ganga Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | - | QoQ Comp | Sep 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1.45 | - | N/A | 1.31 | 11.73% |
| Depreciation/ Amortization | 0.02 | - | N/A | 0.03 | -16.41% |
| Operating Income | -0.14 | - | N/A | 0.05 | 0.00% |
| Net Income | 0.02 | - | N/A | 0.03 | 48.54% |
| Other Operating Expenses Total | 0.52 | - | N/A | 0.40 | 31.89% |
| Net Income Before Taxes | 0.07 | - | N/A | 0.04 | 259.45% |
| Total Revenue | 1.31 | - | N/A | 1.35 | -0.61% |
| Selling/ General/ Admin Expenses Total | 0.29 | - | N/A | 0.26 | 14.34% |
| Diluted Normalized EPS | 0.05 | - | N/A | 0.08 | 25.00% |